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Abstract
OBJECTIVE: This study aimed to (1) generate normative data in healthy boys aged 5–12 years for the six-minute walk test
(6MWT), an outcome measure currently used in clinical trials in Duchenne muscular dystrophy (DMD), (2) to describe the
relation with anthropometric variables and myometry, and (3) to compare our data with published equations.
METHODS: The 6MWT was conducted in 442 boys according to a standardized protocol, as currently used in clinical trials in
DMD. Maximal voluntary isometric contractions for knee flexion and extension were recorded with a hand-held myometer.
RESULTS: The 6MWD increased significantly with age, from 478.0644.1 m at age 5, to 650.0676.8 m at age 12, with the
steepest increase between 5 and 8 years. Age- and height related percentile curves of the 6MWD were developed.
Correlations with anthropometric variables were fair to good (age r = 0.60, height r = 0.57, weight r = 0.44). Myometric
variables (knee flexors and extensors) showed correlations of 0.46 and 0.50 respectively. When dividing into two age
categories (5–8 years, 9–12 years), these magnitudes of correlations only applied to the younger age group. Additionally,
predicted values were calculated according to available reference equations (Geiger and Ben Saad), indicating an
overestimation by those equations. Finally, the Geiger equation was refitted to our population.
CONCLUSION: The percentile curves according to age and height provide a useful tool in the assessment of ambulatory
capacity in boys aged 5 to 12 years. Significant correlations with anthropometric variables and myometry were only found in
the 5–8 years age group. The Geiger prediction equation, currently used to assess ambulatory capacity in DMD was refitted
to obtain a more accurate prediction model based on a large sample with a homogenous distribution across the age
categories 5 to 12 years and applying the methodology as currently used in clinical trials in DMD.
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Introduction
The six-minute walk test (6MWT), a measure of function and
endurance originating from the cardiorespiratory field, assesses the
distance a subject is able to walk in six minutes at a normal pace
(six-minute walking distance, 6MWD) [1]. This measure reflects
the physical capacity and walking function at a submaximal level
and has been accepted as a clinically meaningful outcome measure
by the regulatory authorities in registration-directed clinical trials
in neuromuscular and neurometabolic disorders [2].The 6MWT,
slightly modified from the original American Thoracic Society
guidelines, has been validated in Duchenne Muscular Dystrophy
(DMD), a severe X linked progressive disorder, and is currently
used as (primary) endpoint in therapeutic trials in ambulatory boys
with DMD [3]. Moreover, the correlation of 6MWT with the
Pediatric Outcomes Data Collection Instrument (PODCI), a
Quality of Life (QoL) instrument score, has been reported recently
in DMD [4], confirming its applicability to detect clinically
meaningful changes in ambulant DMD.
The evolution of the 6MWD in DMD is characterized by a
specific pattern: despite of the degenerative character of this
disease, recent studies showed an increment in the 6MWD up to
approximately the age of 7 followed by a decline which becomes
precipitous around the age of 12 years [5–8]. In order to account
for maturational influences, it has been suggested to convert raw
data of the 6MWD into percent predicted values based on
normative data to describe the natural evolution or the impact of
interventions in this disease against the background of growth and
development [9]. This method is commonly applied for other
outcome measures such as respiratory function [10,11].
Different studies have reported normative data and prediction
equations for the 6MWT in healthy children from different ethnic,
environmental and geographical backgrounds [12–20]. However,
data on 6MWT are scarce in young boys of Western European
descent in the age range and according to the procedures currently
used in clinical trials in DMD. Moreover, study methods and
testing procedures differ from one study to another, with different
track lengths and testing instructions or pooling of data from both
genders, hampering further comparison [12–27]. Furthermore,
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recent studies indicated that published equations may over- or
underestimate 6MWD when applied to other populations
[12,15,18,19], highlighting that further research is warranted to
validate the existing equations in large samples of typically
developing children, applying standardized procedures currently
used in DMD trials.
Predictive factors for the 6MWD have been explored such as
age and anthropometric variables, underscoring the influence of
age and height on this outcome measure [12–20]. However, the
impact of other variables such as muscle strength has not yet been
reported in children.
To address those issues, we investigated the 6MWD in typically
developing young boys. In a previous study, we reported on the
reliability of this outcome measure and the developmental
evolution of the 6MWT in narrow age subcategories in boys
between age 5 and 12 years, an age range of particular interest for
clinical trials in ambulant DMD [28]. In this current study, the
data set was further expanded to a larger cohort in order to
generate reference values and percentile curves for the 6MWT in
typically developing boys of this age. A second aim was to
investigate the relation of this functional capacity measure with
age, anthropometric variables and underlying muscle strength.
Finally, we evaluated the applicability of published reference
equations to our population.
Methods
Participants
Typically developing boys aged 5–12 years were recruited from
five randomly selected local primary schools in Belgium between
January and May 2012. Children had to be able to understand
and fully comply with the assessments. A questionnaire to identify
health related problems was completed by the parents a few days
before testing. Children with known chronic cardiac, respiratory,
neurological or musculoskeletal disorders were excluded. Partic-
ipants were sampled across eight age subcategories with one year
interval between 5.0 and 13.0 year and six height subcategories
with 10 cm interval from 105 cm on. The final sample included
also 90 boys from our previously reported reliability study
recruited based on the same in- and exclusion criteria and who
completed the 6MWT according to the same procedure [28].
Ethics statement
Ethical approval was obtained from the institutional committee
of the University Hospitals Leuven (Commissie voor medische
ethiek/klinisch onderzoek UZ Leuven) and the institutional boards
of the participating schools (Basisschool Sint-Jozef Coloma
Mechelen, Vrije Basisschool Putte,Vrije Basisschool De Bunder-
boog Moorslede, Gemeentelijke Basisschool Moorslede, Sint-
Martinus Basisschool Lubbeek, Heilig Hart Instituut Heverlee,
Don Bosco Heverlee, Sint-Romboutscollege Mechelen). Parents of
all children gave their written informed consent.
Test Procedure
The participants’ weight and height were determined using
standardized anthropometric methods before the testing. The
6MWT was conducted according to a standardized protocol, as
described by McDonald et al. [3]. The test was performed in a flat,
straight corridor. Each boy walked for six minutes counterclock-
wise at his preferred pace along a 25 m tape line, with cones
placed at each end of the course. Evaluators gave a standardized
demonstration prior to the test. Subsequently, one practice trial
over one track length was done to ensure that the child understood
the instructions. During the test, each boy was followed by a ‘safety
chaser’ giving limited standardized encouragements.
Testing was performed by three physiotherapists experienced
with the test procedure.
Myometry
Knee flexion and extension strength was measured in both legs
using a calibrated MicroFET2 handheld myometer and expressed
in Newton (N).Testing was performed in a standardized starting
position, sitting with hips and knees in 90u of flexion and no feet
contact with the floor. The investigator fixated the femur above
the knee and placed the handheld myometer at the posterior part
of the calcaneus for knee flexion and at the anterior part of the
shin just proximally to the ankle joint for knee extension [29]. The
highest value of three maximum isometric contractions was
recorded in knee flexors and extensors bilaterally by using the ’
‘make’ technique which requires the patient to exert a maximal
isometric contraction while the examiner holds the dynamometer
in a fixed position.
To rule out the influence of left-right differences, summed scores
for left and right leg were calculated.
Statistical analysis
Descriptive statistics were applied for the different variables
within the total sample and within each age and height group.
Data were tested for normality by Shapiro-Wilk tests and
graphically checked for symmetry.
To construct percentile curves, the following percentiles of
6MWT were estimated for different values of age and height using
a quantile regression analysis: 5%, 10%, 25%, 50%, 75%, 90%
and 95%. The interior algorithm was used to estimate the
regression parameters. The explanatory variables age and height
were included using restricted cubic splines so that no assumptions
had to be made regarding the type of association with the results of
the 6MWT. Correlation analysis between 6MWD and age,
anthropometric, and myometric variables was performed in the
subgroup of 352 subjects in whom myometric data were available.
Pearson product-moment correlation coefficients (r) were calcu-
lated for the total group and for two age categories, from 5 to 8
and 9 to 12 years. Correlation coefficients of .0.70 were
considered as high, between 0.50–0.70 good, between 0.30–0.50
fair and of ,0.30 weak or no association [30].
Measured 6MWDs were compared with the distances predicted
based on the published reference equations by Geiger et al. in
Austria [14] (6MWD (m) = 196.72+39.816 age (years)
21.366age2 (years)+138.286 height (m)) and Ben Saad et al. in
North-Africa [12] (6MWD (m) = 4.636 height (cm) 23.536
weight (kg)+10.426 age (years)+56.32) using parametric paired t-
tests and scatterplots.
Finally, a refitted Geiger model was obtained by applying the
Geiger model to 100 bootstrap samples and averaging the
regression coefficients across all bootstrap samples to obtain the
final estimate of the regression coefficients.
All analyses were performed using SAS software, version 9.2
and SAS Enterprise Guide.
Results
Participant characteristics
In the current study, 368 medical questionnaires were filled out
correctly and returned by the parents. Sixteen children were
excluded based on one or more exclusion criteria (chronic
cardiovascular, respiratory or motor disorders). A total of 442
boys, including the 90 subjects of the first study [28], were
Reference Values and Prediction Equation for 6MWT
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Table 1. Participants characteristics, six-minute walk distance and velocity according to age and height categories (Mean values 6
standard deviation).
N Age (y) Height (cm) Weight (kg) Distance (m) Velocity (m/min)
Age 5 years 57 5.660.3 11565.69 20.762.5 478.0644.1 79.767.4
6 years 52 6.560.3 12166.13 23.663.2 516.1661.8 86.0610.3
7 years 56 7.560.3 12764.41 25.863.4 559.2665.4 93.2610.9
8 years 55 8.560.3 13365.93 29.064.2 604.3672.0 100.7612.0
9 years 60 9.560.3 13965.61 32.866.0 595.7669.0 99.3611.5
10 years 53 10.560.3 14467.28 35.566.2 633.1670.0 105.5611.6
11 years 61 11.460.3 14866.73 39.567.8 625.9683.0 104.3613.8
12 years 48 12.560.3 15466.74 46.767.3 650.0676.8 108.3612.8
Height 105–114 cm 43 5.760.4 11162.43 19.461.9 468.6646.5 78.167.8
115–124 cm 70 6.660.9 12062.83 23.161.9 529.0665.6 88.2610.9
125–134 cm 104 8.061.1 12963.09 27.363.6 576.5667.8 96.1611.3
135–144 cm 100 9.861.2 14062.83 32.764.2 605.3673.3 100.9612.2
145–1541 cm 89 11.260.7 14962.64 40.666.5 631.6680.2 105.3613.4
.155 cm 36 12.160.7 15964.65 49.367.1 651.2688.3 108.5614.7
TOTAL 442 9.062.3 135614.16 31.569.63 582.2688.2 97.0614.7
doi:10.1371/journal.pone.0084120.t001
Figure 1. Plot of estimated percentiles of six-minute walk test versus age. Percentiles 5%, 10%, 25%, 50%, 75%, 90% and 95% of 6MWT
were estimated for different values of age.
doi:10.1371/journal.pone.0084120.g001
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included in the analysis. All boys were of Western European (98%)
or Northern African (2%) descent. Anthropometric data, age,
6MWD and velocity per age and height subcategory are reported
in Table 1. Mean age, height and weight of the total group were
9.062.3 years, 135614.16 cm and 31.569.63 kg respectively.
6MWD and velocity
Descriptive data of 6MWD and velocity are given in
Table 1.The overall mean 6MWD was 582.2688.2 m. Mean
6MWD increased between the age of 5 and 12 from
478.0644.1 m to 650.0676.8 m. In parallel, velocity increased
from 79.767.4 m/min at 5 years to 108.3612.8 m/min at 12
years. The steepest increase was observed between the age of 5
and 8 years (from 478.0 m to 604.3 m). Beyond this age, the
6MWD tended to stabilize (from 604.3 m to 650.0 m). In the
height subcategories, distance increased significantly across the
board with an increase of mean 6MWD from 468.6646.5 m in
the smallest boys up to 651.2688.3 m in the tallest boys with
Figure 2. Plot of estimated percentiles of six-minute walk test versus height. Percentiles 5%, 10%, 25%, 50%, 75%, 90% and 95% of 6MWT
were estimated for different values of height.
doi:10.1371/journal.pone.0084120.g002
Table 2. Mean values (standard deviation) of myometric variables for the total group and according to eight and two age
categories.
Total group Eight age categories Two age categories
5–12 years 5 years 6 years 7 years 8 years 9 years 10 years 11 years 12 years 5–8 years 9–12 years
N 352 42 42 43 45 46 44 48 42 172 180
Myometric variables
Flexors 189.2 127.0 143.0 168.4 182.0 194.1 219.4 214.7 260.2 155.6 221.2
(N) (53.9) (27.1) (28.3) (30.5) (25.0) (32.5) (45.5) (45.9) (48.8) (34.9) (49.2)
Extensors 346.8 221.1 250.3 301.6 328.5 366.8 417.4 405.5 472.3 276.5 414.1
(N) (112.7) (39.3) (55.0) (55.0) (65.4) (97.2) (87.1) (97.3) (121.4) (65.8) (107.0)
doi:10.1371/journal.pone.0084120.t002
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velocities of respectively 78.167.8 m/min to 108.5614.7 m/min.
A mild flattening was seen from a height of 140 cm.
Percentile curves according to age and height
Percentiles 5%, 10%, 25%, 50%, 75%, 90% and 95% of
6MWT were estimated for different values of age and height and
are shown in Figures 1 and 2.
Myometry
Myometry data were obtained in 352 subjects. The mean
muscle strength 6 SD for the total group for the knee flexors and
extensors was 189.2653.9N and 346.86112.7N, respectively
(Table 2). Muscle strength increased with age for both knee
flexors and extensors. Myometric variables were also calculated for
the two age cohorts of 5 to 8 and 9 to 12 years.
Correlations of 6MWD with age, anthropometric and
myometric variables
Correlations between 6MWD and predictive variables were
calculated for the total group and for the two age subcategories (5
to 8 and 9 to 12 years) (Table 3). For the total group, height and
weight were significantly correlated with the 6MWD (r = 0.57;
r = 0.44 respectively, p,0.0001). Age showed the highest corre-
lation with the 6MWD (r = 0.60; p,0.0001).
The 6MWD showed a fair to good correlation with knee flexion
(r = 0.46; p,0.05), and knee extension (r = 0.50; p,0.05).
Inspection of the correlation coefficients in the two age subcate-
gories revealed a clear difference between both groups. In the
younger children, significantly higher correlations were found
between all variables and 6MWD, compared to the older children.
Anthropometric factors showed a good correlation with the
6MWD in the young age category, with coefficients above 0.50
while in the older age group, no to weak associations were found.
The same trend was observed for the myometric variables,
showing fair to good correlations in the younger age category
(r = 0.46 – 0.52) and weak or no association with 6MWD in the
older age group.
6MWD reference equation
Table 4 compares our results to mean values of previous
6MWT studies in healthy children from different countries and
ethnicities. Differences in methodology between these studies are
summarized in table 5.Overall, data measured in Austrian [14]
and North African boys [12] were higher in comparison with the
present study. In contrast, measured data in children from U.S,
U.K and South America were clearly lower [15,16,20].
A comparison with previously published reference equations
was performed by calculating predicted values for our measured
data based on the reference equations of Geiger et al. [14] and Ben
Saad et al. [12]. Mean differences between our actual measured
values and the predicted values by Geiger et al.[14] and Ben Saad
et al. [12] were 233.7 m (95% CI 27.3 m – 40.1 m) and 276.1 m
(95% CI 69.5 m – 82.6 m) respectively, indicating a significant
difference (both p,0.0001).
Comparison with Geiger prediction model
Figure 3 illustrates the observed 6MWD versus the predicted
values based on the Geiger equation. This application resulted in a
systematic overestimation with an associated R2 value of 0.17.
Therefore the Geiger model was refitted for our population with
resulting R2 value of 0.41. The following refitted Geiger equation
was obtained:
6MWD=86.795 + 74.5476 age (years) 23.0186 age2 (years)
+63.2046 height (m).
Figure 4 shows the predicted versus observed 6MWT results for
the refitted Geiger equation, indicating a better distribution
around the identity line.
Discussion
This study established normative data for the 6MWT, provided
age- and height specific centile curves and investigated its
correlation with age, anthropometric and myometric variables in
a large cohort of 442 healthy boys aged 5–12 years, an age group
of particular interest in relation to studies in ambulant DMD boys.
In addition, a comparison with previously published reference data
and prediction equations was made and the commonly used
Geiger equation was refitted for this population. To our
knowledge, this is the largest dataset reporting on 6MWT in
typically developing boys of this age range, using the methodology
and track length currently applied in DMD studies [3].
Our findings confirmed previous reports of a significant
improvement in 6MWD with increasing age [16,28]. The
strongest increase was found between the age of 5 and 8 years,
which is in accordance to previous reports from Austrian [14] and
British children [16]. After the age of 8 years, 6MWD tends to
stabilize despite a further evolution of the anthropometric
variables [12,14,16], which may possibly be explained by the
developmental maturity of the human gait pattern and muscle
activation patterns at this age. Moreover, the velocity of the
walking pattern has a known physiological limit from approxi-
mately 5 km/h [31,32]. At higher velocity there is a dispropor-
tionate increase in energy expenditure, indicating that in older
children where a full maturation of gait pattern is achieved, a
switch to a running pattern is more economical from an energy
standpoint and required to further increase velocity. It should,
however, be noted that DMD subjects are typically unable to run
due to their muscle weakness and generally show a decline in
6MWD after the age of 8.
A steady increase was noticed over the height subcategories,
followed by a flattening of the curve from height 135 cm on, which
is in accordance with the data of Lammers et al [16]. Both age-
and height specific centiles curves were constructed, which could
provide a user-friendly method in the prediction of 6MWD in boys
of this age range. We were particularly interested in investigating
the relation of the 6MWD with height and to provide height
specific references in addition to the age specific normative data, as
Table 3. Correlation coefficients between six-minute walk
distance and anthropometric and myometric variables for the
total group and for two age categories with statistical
comparison.
Total
group Two age categories z-value p-value
5–12 years 5–8 years 9–12 years
N 352 172 180
Age 0.60* 0.65* 0.16* 5.71 p,0.0001
Weight (kg) 0.44* 0.50* 20.02 5.29 p,0.0001
Height (cm) 0.57* 0.60* 0.09 5.61 p,0.0001
Flexors (N) 0.46* 0.46* 0.08 3.88 p = 0.0001
Extensors (N) 0.50* 0.52* 0.16* 3.86 p = 0.0001
*p,0.05
doi:10.1371/journal.pone.0084120.t003
Reference Values and Prediction Equation for 6MWT
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those could be useful in DMD boys, known to have a stunted
growth compared to their peers, which is aggravated by the
chronic use of corticosteroids.
Height specific reference centiles have been published based on
data from 805 boys and 610 girls from Chinese ethnicity (aged 7–
16 years) [17]. Comparison of the reported mean 6MWD and
inspection of the centile curves for boys indicated slightly higher
values for the Chinese population compared to our sample. This
difference could be explained by differences in methodology, with
the use of a longer track length in the Chinese study and/or by
ethnic differences as suggested by other authors [12,15,18].
A second aim was to investigate the correlation of age,
anthropometric variables and leg strength with the 6MWD. The
highest correlation was found for age and height with correlation
coefficients of 0.60 and 0.57 respectively, which confirms
previously reported findings [12,14,16,17,20]. A fair to good
correlation was found between 6MWD and muscle strength in
knee flexors and extensors. However, these magnitudes of
correlations appeared mainly driven by the age group 5 to 8
years and disappeared in the older age group. Discordance
between muscle strength and function tests has been reported by
other authors [33]. Finally, our data indicated that additional
factors to age, anthropometric and myometric variables influence
the 6MWD, which requires further investigations, especially in
older children. Genetic predisposition, motor abilities, physical
fitness and training as well as motivation of the individual child
during a self-paced test may further impact on the measured
6MWD.
In addition, we aimed to compare our normative data with
previous reports. Literature review revealed eight studies [12–
18,20] that reported measured values and/or prediction equations
for the 6MWT in healthy children from different ethnic,
environmental and geographical backgrounds. Our 6MWD data
showed consistently lower values than the measured values of
Geiger et al. [14] and Ben Saad et al. [12]. Adversely, measured
6MWDs in North American [15], British [16], and South
American boys [20] were lower than our measured values.
However, a direct comparison of our findings to the reference
values reported should be done cautiously since different testing
procedures were applied and pooling of data for age and gender
was done differently across studies [12–14,16,17,20]. Differences
in testing procedures may contribute to the variability in distances
Figure 3. Predicted versus observed six-minute walk test data for the Geiger equation. The observed 6MWT data were plotted against the
predicted data based on the Geiger equation applied to our study sample (R2 = 0.17).
doi:10.1371/journal.pone.0084120.g003
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walked in six minutes, such as influencing the motivation of the
child with the use of a measuring wheel [14] or interfering with the
test procedure by measuring additional variables [16]. The
influence of track length on a child’s 6MWD is also not clear
from previous reports [1,15]. Furthermore, the pooling of data
from both genders [16,20] may possibly explain the lower
achieved distances in those studies, although reports on the
influence of gender are conflicting [14–17,20].
The sample sizes were highly variable as well, with some studies
reporting data from very limited samples [15]. Finally, the
different ethnical backgrounds as well as anthropometric differ-
ences may further explain some of the variability across the
different studies [12,15,18].
This study was set up to collect data on 6MWT in typically
developing children as a reference for DMD boys. In this
progressive disease of childhood, muscle loss and functional
decline occur against a background of growth and development,
resulting in the observation of an increase in 6MWD in younger
children with DMD despite progressive impairment [5–8].
Converting raw 6MWD values into percentage predicted values
based on a reference equation derived from age- and height
matched peers seems the most straightforward method to account
for those maturational influences [9]. Henricson et al.[9]
concluded that the equation of Geiger et al. [14] was the most
appropriate for their American DMD boys because of the large
age range, Caucasian ethnicity and absence of heart rate as an
independent variable. This equation has been derived from data
collected from 280 healthy Austrian boys, unequally distributed
between age 3 and18 years, with the largest sample in the age
category 12 to 15 years, using a slightly different testing procedure
(use of a measuring wheel, running allowed in the younger ones,
20 m track). We questioned whether this equation would be the
most accurate for our sample as well.
When implementing the data of our study into the Geiger
equation [14], the mean predicted value was higher than the
originally measured value. This overestimation was observed in all
age categories. The same observation was made for the North
African reference equation [12]. As the Geiger equation has yet
been implemented in DMD studies, we refitted this equation to
our population to obtain a more accurate prediction model based
on a larger sample with a homogenous distribution across age
Figure 4. Predicted versus observed six-minute walk test results for the refitted Geiger equation. The observed 6MWT data were plotted
against the predicted data based on the refitted Geiger equation applied to our study sample (R2 = 0.41).
doi:10.1371/journal.pone.0084120.g004
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categories and applying a methodology as currently used in clinical
trials in DMD.
This study is prone to several possible limitations. First, the data
were obtained by a team of three different testers. Nonetheless, to
limit possible inter-rater variation, all evaluators were well trained
and followed a standardized operational protocol. Secondly, this
study did not investigate parameters of endurance such as heart
rate at baseline and post exercise, a variable reported to correlate
with 6MWD [17,20]. However, this study was set up to explore
variables that could be useful in relation to DMD. In this disease a
higher baseline heart rate and stunted reactions of heart rate to
exercise have been reported [3], impeding the use of those
variables in equations derived from healthy boys. Finally, our data
were limited to elementary school boys aged 5 to 12 years. Further
studies are required to generate data in pubertal and adolescent
boys, especially since loss of ambulation has shifted to an older age
in the contemporary natural history of DMD boys under chronic
steroid treatment [34].
Despite these limitations, this study was the first to establish
normative data of the 6MWT in a large cohort (N= 442) of
healthy boys (5–12 years) and this in relation to age and height,
using the same methodology as currently used in DMD studies
[3].The normal values were measured in narrow age subcategories
of one year with each category containing minimum 48 children.
This study provided age- and height specific centile curves which
might be clinically useful to judge the performance of DMD boys,
the evolution of the DMD disease and the response to therapeutic
intervention. This study confirmed previous reports on correla-
tions between 6MWD with age and anthropometric variables in
young children. It was however the first study to explore relations
between myometric variables and the 6MWT in a large cohort of
healthy subjects. Our study indicated that those variables do
influence the 6MWD, especially up to the age of 9, however
further research is required to identify additional factors influenc-
ing the 6MWT, especially in the older age group. Finally, the
Geiger prediction equation, which use has been advocated for
DMD studies, was refitted to this large sample of boys aged 5 to 12
years.
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